Data: 08/08/2026
Total encontrado: 18
1/18US=22 / Urologia
Mizutani Y, kawauchi A, Bonavida B, Miki T. Smac/DIABLO: a proapoptotic molecular target in renal cell cancer. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 335-46. ISBN 978-1-58829-737-2.

CARCINOMA DE CELULAS RENAIS; SMAC / DIABLO; PROGNOSTICO; APOPTOSE; CISPLATINA; XIAP; RCC; TRAIL

2/18US=85 / Biol/Mol
Plantivaux A, Szegezdi E, Samali A, Egan L. Is there a role for nuclear factor kB in tumor necrosis factor-related apoptosis-inducing ligand resistance?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 38-49. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CANCER; APOPTOSE; RESISTENCIA; INIBIDORES DE PROTEASSOMA; SUPER-REPRESSOR; MTOR; TRAIL; NF-KB

3/18US=85 / Biol/Mol
Corazza N, Kassahn D, Jakob S, Badmann A, Brunner T. TRAIL-induced apoptosis: between tumor therapy and immunopathology. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 50-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

TRAIL; HEPATOCITOS; APOPTOSE; TUMOR; LESAO HEPATICA; BIM; JUN QUINASE

4/18US=89 / Biol/Mol
Griffith TS. Induction of tumor cell apoptosis by trail gene therapy. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 315-34. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9.

INDUCAO DE APOPTOSE; TUMOR; TERAPIA GENETICA; TRAIL; ADENOVIRUS; APOPTOSE; TRANSFERENCIA DE GENES

5/18US=49-G / Câncer
Rahman M, Pumphrey JG, Lipkowitz S. The TRAIL to targeted therapy of breast cancer. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2009. p. 43-73. ISBN 978-0-12-3747730.

TRIAL PARA TERAPIA-ALVO DO CANCER DE MAMA; TRIAL E RECEPTORES; APOPTOSE INDUZIDA POR TRAIL EM CELULAS DE CANCER DE MAMA; SUPERAR A RESISTENCIA TRAIL

6/18US=13 / Biol/Mol
Pecorino L. Apoptosis. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 137-59. ISBN 978-0-19-921148-7.

APOPTOSE; MECANISMOS MOLECULARES; VIA EXTRINSECA; VIA INTRISECA; RECEPTORES DE MORTE DA MEMBRANA; MITOCONDRIAS; GENE P53; CANCER; RECEPTORES TRAIL; QUIMIOTERAPIA; DROGAS ANTI-NEOPLASICAS APOPTOTICAS; BCL-2

7/18US=39 / Câncer
Yoshida T, Sakai T. Agents that regulate DR5 and sensitivity to TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 41-9. ISBN 978-1-58829-989-5.

AGENTES; DR5; TRAIL

8/18US=39 / Câncer
Bonavida B, Huerta-Yepez S, Vega MI, Spandidos DA, Baritaki S. Nitric oxide-induced immunosensitization to apoptosis by Fas-L and TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 203-10. ISBN 978-1-58829-989-5.

IMMUNOSENSIBILIZACAO; OXIDO NITRICO; APOPTOSE; FAS-L; TRAIL

9/18US=56 / Biol/Mol
Walczak H, Haas TL. Biochemical analysis of the native TRAIL death-inducing signaling complex. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 221-39. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

TRAIL; APOPTOSE; DISC; IMUNOPRECIPITACAO; CASPASE

10/18US=70 / Biol/Mol
Bunz F. Cancer genetics in the clinic. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 259-79. ISBN 978-1-4020-6783-9.

GENETICA DO CANCER; CLINICA; INFORMACAO GENETICA; CARCINOGENOS; GENES; CELULAS GERMINATIVAS; ALTERACOES GENETICAS; BIOMARCADORES; TERAPIA ANTI-CANCER; BCR-ABL; IMATINIBE; GEFITINIBE; TRAIL

11/18US=86 / Biol/Mol
Humphreys RC, Halpern W. Trail receptors: targets for cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 127-58. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8.

TERAPIA DO CANCER; RECEPTORES TRAIL; APOPTOSE; ANTICORPOS MONOCLONAIS

12/18US=86 / Biol/Mol
Kuribayashi K, El-Deiry W. Regulation of programmed cell death by the P53 pathway. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 201-21. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8.

REGULACAO DA MORTE CELULAR PROGRAMADA; VIA P53; APOPTOSE; TRANSCRICAO; RECEPTORES TRAIL; MORTE CELULAR DEPENDENTES DE P53

13/18US=86 / Biol/Mol
Shankar S, Srivastava RK. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HAC inhibitor-induced apoptosis. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 261-98. (Advances in Experimental Medicina and Biology volume 615) ISBN 978-1-4020-6553-8.

INIBIDORES DE HISTONA DESACETILASE; CANCER; APOPTOSE INDUZIDA POR INIBIDORES; INIBIDORES HDAC; HAT; SAHA; MS-275; TSA; TRAIL; CASPASE

14/18US=16 / Urologia
Jiménez JA, Li X, Gardner TA, Kao C. Biology and imaging: gene therapy for advanced prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 139-63. (Contemporary Cancer Research) ISBN 978-1-58829-696-2.

BIOLOGIA; IMAGEM; TERAPIA GENICA; CANCER DE PROSTATA AVANCADO; AAV; AD5/35; ADENOVIRUS; GVAX; HSV-TK; TERAPIA VIRAL ONCOLITICO; OSTEOCALCINA; VACINA; HSP; TRAIL

15/18US=92 / Biol/Mol
Ricci MS, El-Deiry WS. Apoptosis and alternative modes of cell death: the extrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 31-54. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

APOPTOSE; TNF; FAS; TRAIL; NF-KB; QUIMIOTERAPIA; RECEPTOR MORTE; RECEPTOR CHAMARIZ; VIA EXTRINSECA; AUTOIMUNIDADE

16/18US=92 / Biol/Mol
Fulda S, Debatin KM. Recent and developing cancer therapies: modulation of TRAIL signaling for cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 579-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

APOPTOSE; TRAIL; DROGAS; TERAPIA DO CANCER

17/18US=2 / Biol/Mol
Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5.

RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS

18/18US=882 / Tese/FAP
Ferreira SMI. Análise comparativa do perfil imune no sangue de pacientes metastáticos enão metastáticos com câncer de pulmão de não pequenas células. [Comparative analysis of the immune profile in blood of patients with non small cell lung cancer]. São Paulo, 2020. 51 p. Dissertação(Mestrado)-Fundação Antonio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2020/SMIFerreira/SMIFerreira.pdf

Curriculum Lattes

CARCINOMA DE PEQUENAS CELULAS DO PULMAO; MICROAMBIENTE TUMORAL; METASTASE NEOPLASICA; PROGNOSTICO; BIOMARCADORES TUMORAIS